Inflammation and thrombotic risk in late-stage cervical cancer: An exploratory study of coagulation and cytokine profiles in a South African cohort

•Direct links between inflammation and thrombosis in cervical cancer remain underexplored.•The study uses TEG, cytokine analysis, and microscopy to assess thrombotic risk profiles.•Findings suggest potential benefits of targeting IL-1 to reduce thrombotic risk.•Results highlight the need for persona...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cytokine (Philadelphia, Pa.) Pa.), 2024-12, Vol.184, p.156782, Article 156782
Hauptverfasser: Fourie, Louise, Christowitz, Claudia, Eksteen, Carla, van der Merwe, Haynes, Botha, Hennie, Venter, Chantelle, Engelbrecht, Anna-Mart
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Direct links between inflammation and thrombosis in cervical cancer remain underexplored.•The study uses TEG, cytokine analysis, and microscopy to assess thrombotic risk profiles.•Findings suggest potential benefits of targeting IL-1 to reduce thrombotic risk.•Results highlight the need for personalised treatment strategies in cervical cancer care. This exploratory study investigates the possible relationship between inflammation and thrombosis in cervical cancer patients in South Africa, highlighting the need for improved thrombotic risk profiling. Thromboelastography (TEG) was used to assess coagulation parameters in platelet-poor plasma (PPP) from a small cohort of late-stage (III and IV) cervical cancer patients (n = 19) and healthy controls (n = 15). Parameters assessed included clotting time, clot formation speed, and clot strength. A Luminex Multiplex assay was used to measure interferon-γ (IFN-γ), interleukin-1β (IL-1β), IL-6, vascular endothelial growth factor-A (VEGF-A), and tumour necrosis factor-α (TNF-α) in PPP. Haematological profiles were also evaluated. Cervical cancer patients displayed a significantly shortened clotting time (p = 0.0044) and increased clot strength (p = 0.0003), suggesting enhanced coagulation. IL-1β was notably elevated (p = 0.0200), consistent with an inflammatory environment. Higher lymphocyte, neutrophil, and platelet counts (p = 0.0162, 0.0420, and 0.0374, respectively) were observed, indicating a possible prothrombotic state. These findings suggest a potential link between inflammation and thrombosis in cervical cancer patients. However, due to this study’s small sample size and exploratory nature, direct relationships between these factors have yet to be definitively established and remain speculative. Thrombotic risk profiling may still offer value in managing patients, but further investigation is required to confirm these preliminary observations.
ISSN:1043-4666
1096-0023
1096-0023
DOI:10.1016/j.cyto.2024.156782